Skip to main content

What the FDA labels say about taking them together

Enalaprilat and triamterene

Enalaprilat's FDA label of June 7, 2024 names triamterene in its drug interactions section; triamterene's label does not name enalaprilat itself but warns about its class (ACE inhibitors). The enalaprilat label: “Potassium-sparing diuretics, potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.”

Check it at the source: the enalaprilat FDA label on DailyMed (effective June 7, 2024, Dr. Reddys Laboratories Inc); the triamterene FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the enalaprilat label say about triamterene?

Enalaprilat label, drug interactions

Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.

Source: FDA drug label (Enalaprilat), Dr. Reddys Laboratories Inc, effective June 7, 2024 (SPL set 5d398da1-020c-ccb1-a775-ce8e0b29d621), via openFDA; the full label on DailyMed

What does the triamterene label say about enalaprilat?

Triamterene's label does not name enalaprilat itself; it warns about its class (ACE inhibitors):

Triamterene label, drug interactions

Potassium-sparing agents should be used with caution in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to an increased risk of hyperkalemia.

Source: FDA drug label (Dyrenium), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set ebb177c0-d45d-4443-a85a-e76bd9931a42), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Enalaprilat generic labelers
3Triamterene generic labelers
EnalaprilatTriamterene
Labeled forHigh blood pressureHeart failure, Edema (fluid retention)
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$5.98 per capsule 50 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?